Docusign
DOCU · NYSE · Information Technology
+$0.48 today
- Mkt cap $8.60B
- P/E 29.2
- Day $43.48 – $45.12
Confidence
High conviction
The read
Docusign Q1 EPS beats estimates by 10%, but cautious ARR growth and IAM concerns weigh
Docusign reported Q1 EPS of $1.09, beating estimates by 10%, yet the stock declined 1.3% amid cautious guidance on ARR growth and uncertainty around IAM platform adoption.
Confidence note: EPS beat is confirmed and valuation metrics are supportive, but growth outlook and IAM platform adoption remain uncertain.
What happened
Earnings print
Guidance
Price reaction
Street narrative
So what
What changed
What the market is pricing
Fundamental takeaway
Next 30–90 days
ARR growth accelerates and IAM platform gains meaningful customer traction, driving multiple expansion.
- boltARR growth guidance upgrades in next quarterly report
- boltPositive customer adoption metrics for IAM platform
ARR growth remains modest with gradual IAM platform adoption, supporting stable valuation.
- boltStable ARR growth near current guidance
- boltIncremental IAM platform customer wins
ARR growth disappoints and IAM platform fails to gain traction, pressuring multiples and valuation.
- boltARR growth guidance cuts in next 1-2 quarters
- boltNegative commentary or metrics on IAM platform
What to do
If you hold it
If you're watching
Keep on your radar
- Next quarterly ARR growth guidance (expected within 90 days)
- IAM platform customer adoption updates
- Stock price relative to $44.55 current level and $58.85 analyst target
- Institutional ownership trends and insider activity